June 26 (Reuters) - Cleo Diagnostics Ltd (COV) :
- COMMENCES U.S. REGULATORY PROCESS WITH FDA
- COMPLETED AN INITIAL PRE-SUBMISSION MEETING WITH FDA
- OUTLINED ITS SUBMISSION FRAMEWORK AND CLINICAL PLAN FOR ITS OVARIAN CANCER DETECTION BLOOD TEST WITH FDA
(([email protected];))
News: COV Cleo Diagnostics Commences U.S. Regulatory Process With FDA
Add COV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.005(1.35%) |
Mkt cap ! $29.78M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.5¢ | $32.11K | 87.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19300 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 47027 | 1 |
View Market Depth
| Last trade - 15.36pm 01/11/2024 (20 minute delay) ? |
| COV (ASX) Chart |